Exchange: NASDAQ·Updated 12:28 PM EDT
MACA logo

MACA Moringa Acquisition Corp - Ordinary Shares - Class A

$1.91
$0.05
(2.55%)
Today
Mkt Cap$6.53M
Vol105.00

About MACA

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
50

Neutral Sentiment

How do you feel about MACA?

Advertisement|Remove ads.